Cardiology
- Aspirin in primary prevention of cardiovascular events: Key questions remain
Are we done with the issue of aspirin in primary prevention? Not quite yet.
- Aspirin for primary prevention of cardiovascular disease: What do the current USPSTF guidelines say?
A concise overview of the US Preventive Services Task Force recommendations.
- Heart failure with reduced ejection fraction: What’s new in the 2022 guideline?
Evidence-based and guideline-based medical therapies can help patients feel better, stay out of the hospital, live longer, and potentially improve left ventricular function.
Resistant hypertension: A stepwise approachThe authors review the definition and prevalence of resistant hypertension and its diagnostic workup and management, including lifestyle modifications, drugs, and experimental therapies.
- A 50-year-old man presents with shortness of breath
Red flags included low voltage, normal sinus rhythm, and Q waves on electrocardiography, a history of carpal tunnel syndrome, and evidence of renal dysfunction.
- Some complexities of diabetes and the heart
Patients with diabetes are at greater risk of coronary artery disease than their peers without diabetes. That’s straight and simple. But there the simplicity ends.
- Statins may increase diabetes, but benefit still outweighs risk
The weight of the evidence suggests that statin use is associated with an increased risk of new-onset diabetes mellitus, but the magnitude of the effect has varied across studies.
- Decongesting heart failure with diuretics: Easier to prescribe than to fully understand
Digging deep into the pathophysiology of diuretic resistance reveals complex interacting pathways. But none of these pathways can fully explain or be used to safely reverse diuretic resistance.
